SCHEMBL674356

SCHEMBL674356

c1ccc2c(-c3cc[nH]n3)cccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.42
KDM4E B2RXH2 5/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
GSK3B P49841 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
ALPL P05186 1/20 0.40
GAA P10253 1/20 0.40
TYMP P19971 1/20 0.39
NOS1 P29475 1/20 0.38
ENPP3 O14638 1/20 0.38
ENPP1 P22413 1/20 0.38
TP53 P04637 2/20 0.38
MAPT P10636 2/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30589021 1.00 NISCH (0.42) NISCHKDM4EMEN1KMT2AGSK3B
SCHEMBL27596511 1.00 NISCH (0.42) NISCHKDM4EMEN1KMT2AGSK3B
SCHEMBL28421923 0.85 ALDH1A1 (0.33) MEN1KMT2AGSK3BCDK5CDK5R1
SCHEMBL27373163 0.84 GSK3B (0.36) NISCHKDM4EMEN1KMT2AGSK3B
SCHEMBL28955029 0.83 DNMT1 (0.44) NISCHKDM4EMEN1KMT2AGSK3B
SCHEMBL27762988 0.81 KDM4E (0.35) NISCHKDM4EMEN1KMT2AGSK3B
SCHEMBL27628456 0.80 KMT2A (0.47) KDM4EMEN1KMT2AGSK3BCDK5
SCHEMBL11852245 0.80 CYP1A2 (0.47) KDM4EMEN1KMT2AALDH1A1HPGD
SCHEMBL26905316 0.76 POLB (0.40) NISCHKDM4EMEN1KMT2AALDH1A1
SCHEMBL3252001 0.76 IDO1 (0.55) KDM4EMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233766-B Naphthalene ring-pyrazole compound and preparation method and application thereof 贵州医科大学 2022-07-01 CN claimed
CN-111233766-A Naphthalene ring-pyrazole compound and preparation method and application thereof 贵州医科大学 2020-06-05 CN claimed
US-8053090-B2 Phosphorescent multinuclear copper complex and organic electroluminescent device using the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-11-08 US claimed
US-8039123-B2 Phosphorescent heteronuclear copper(I)-iridium(III) complex and organic electroluminescence device using the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-10-18 US claimed
US-20070267959-A1 Phosphorescent heteronuclear copper(I)-iridium(III) complex and organic electroluminescence device using the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-11-22 US claimed
US-20070270592-A1 Phosphorescent multinuclear copper complex and organic electroluminescent device using the same SAMSUNG DISPLAY CO., LTD. (KR) 2007-11-22 US claimed
CN-101074237-A Phosphorescent multinuclear copper complex and organic electroluminescent device using the same SAMSUNG SDI CO LTD (KR) 2007-11-21 CN claimed
US-7294415-B2 Organometallic complex and organic electroluminescent device employing the same SAMSUNG SDI CO., LTD. (KR) 2007-11-13 US claimed
US-20040265633-A1 Organometallic complex and organic electroluminescent device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2004-12-30 US claimed
US-20250281465-A1 MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-09-11 US disclosed
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF Genetic Intelligence, Inc 2023-08-31 US disclosed
CN-107801390-B Process for the manufacture of 1-cyclopropylnaphthalene 帕西昂奥地利有限两合公司 2021-12-21 CN disclosed
US-10683245-B2 Process for manufacturing 1-cyclopropyl-naphthalenes PATHEON AUSTRIA GMBH & CO. KG (AT) 2020-06-16 US disclosed
CN-107382782-B Method for synthesizing polyaryl substituted naphthol derivative 绍兴文理学院 2020-05-12 CN disclosed
US-20030073218-A1 High affinity inhibitors for target validation and uses thereof PRINCETON UNIVERSITY 2003-04-17 US disclosed
US-6383790-B1 PYRAZOLO(3,4-D)PYRIMIDINE BASED COMPOUND; ANTICARCINOGENIC AGENTS; ANTITUMOR AGENTS PRINCETON UNIVERSITY 2002-05-07 US disclosed
EP-1140938-A2 HIGH AFFINITY INHIBITORS FOR TARGET VALIDATION AND USES THEREOF Princeton University (US) 2001-10-10 EP disclosed
WO-2000042042-A2 HIGH AFFINITY INHIBITORS FOR TARGET VALIDATION AND USES THEREOF PRINCETON UNIVERSITY (US) 2000-07-20 WO disclosed
US-5202218-A Diffusion transfer MITSUBISHI PAPER MILLS LIMITED (JP) 1993-04-13 US disclosed
US-4873170-A EXPOSURE OF EMULSION LAYER CONTAINING SENSITIZING DYE; SCUM FREE MITSUBISHI PAPER MILLS, LTD. (JP) 1989-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070267959-A1 Phosphorescent heteronuclear copper(I)-iridium(III) complex and organic electroluminescence device using the same ORC3, AP3M1, PUF60 NISCH 574/4885KDM4E 3707/4885MEN1 873/4885
US-20040265633-A1 Organometallic complex and organic electroluminescent device employing the same TYR, CYBA, LAGE3 NISCH 265/4885KDM4E 2310/4885MEN1 2363/4885
US-20230272401-A1 COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF TARDBP, FUS, RBM17 NISCH 4836/4885KDM4E 2645/4885MEN1 4364/4885
US-20250281465-A1 MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE ORAI1, CHERP, CASR NISCH 4295/4885KDM4E 3336/4885MEN1 2803/4885
US-10683245-B2 Process for manufacturing 1-cyclopropyl-naphthalenes KCNK17, CYP1B1, BCKDK NISCH 100/4885KDM4E 595/4885MEN1 1417/4885
US-20030073218-A1 High affinity inhibitors for target validation and uses thereof SRC, MARCKS, TEC NISCH 3989/4885KDM4E 1129/4885MEN1 3818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.